China's Dominance in Pharmaceutical Ingredients Poses a National Security Threat Requiring Domestic Manufacturing Investment
Source: "China controls 45% of global pharmaceutical ingredients, US at 3% | Fox News." September 14, 2026. www.foxnews.com
The Gist
The author argues that America is dangerously dependent on China for medicines and drug ingredients, and that China could use this dependence as a weapon against the US in a crisis. She says the solution is to invest heavily in building pharmaceutical factories in America, using Ohio's semiconductor manufacturing success as a model, rather than relying only on laws and tariffs.
Conclusion
The United States must urgently invest in domestic pharmaceutical manufacturing capacity to end its dependence on China for essential medical ingredients, because this dependence constitutes a critical national security vulnerability that China could weaponize.
Premises
- The US produces only about 3% of active pharmaceutical ingredients globally, while China produces 45%, and China supplies over 60% of essential components for US antibiotics.
- This represents a dramatic decline from 1981, when the US produced 25% of the world's pharmaceutical ingredients, showing a trend of increasing dependency.
- China has already demonstrated willingness to weaponize supply chains in other sectors, including rare earths, semiconductor inputs, and defense-critical metals.
- The same Chinese chemical supply networks that feed US pharmacies also feed the fentanyl pipeline through Mexican cartels, causing thousands of deaths.
- Legislative measures like the BIOSECURE Act and tariffs, while helpful, do not build physical manufacturing capacity and are insufficient on their own.
- States like Ohio have successfully built domestic manufacturing hubs (e.g., semiconductors) through combined investment, infrastructure, and workforce development, providing a replicable model for pharmaceutical manufacturing.
- Military readiness, border security, and public health all depend on secure access to medications, which is currently compromised by foreign dependency.
Assumptions
- China would actually choose to weaponize pharmaceutical supply chains against the US, despite economic interdependence and potential consequences to China itself.
- Domestic manufacturing capacity can be built quickly and at scale to meaningfully replace Chinese supply within a relevant timeframe.
- The cost of building domestic manufacturing infrastructure would be justified by the security benefits, i.e., that this is economically and politically feasible.
- Past behavior in other sectors (rare earths, semiconductors) is a reliable predictor of future behavior in pharmaceuticals.
- Government incentives can effectively induce private companies to build advanced manufacturing facilities in the US.
- The fentanyl crisis and legitimate pharmaceutical supply chains share enough structural similarity to be treated as parts of the same national security problem.